Siddhesh Joshi (Editor)

David Jack (scientist)

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Citizenship
  
British

Doctoral advisor
  
Arnold Beckett

Residence
  
United Kingdom

Role
  
Scientist

Name
  
David Jack


David Jack (scientist) itelegraphcoukmultimediaarchive02058jackpo

Born
  
22 February 1924 Markinch, Fife, Scotland (
1924-02-22
)

Institutions
  
Allen & Hanburys, Glaxo

Alma mater
  
University of Glasgow Royal Technical College University of London

Known for
  
Drug discovery and development

Spouse
  
Lydia Downie Brown (1952–)

Died
  
November 8, 2011, Hertfordshire, United Kingdom

Education
  
University of London, Royal College of Science and Technology, University of Glasgow

Fields
  
Pharmacology, Medicinal chemistry

Notable awards
  
Royal Society of Edinburgh, Order of the British Empire, Mullard Award, Royal Society, Knight Bachelor

Sir David Jack CBE FRS FRSE (22 February 1924 – 8 November 2011) was a Scottish pharmacologist and medicinal chemist who specialised in the development of drugs for treating asthma. He was head of research and development at Glaxo from 1978 until 1987.

Contents

David Jack (scientist) Sir David Jack Pioneering chemist who revolutionised the treatment

Early life and education

Jack was born the sixth and youngest child of a coal miner, in Markinch, Fife, Scotland. He attended Buckhaven High School before turning down a place at Edinburgh University to become an apprentice pharmacist. In 1944, having completed his apprenticeship, he began a BSc course in chemistry and pharmacy at the Royal Technical College, Glasgow. He won a number of undergraduate prizes and graduated with first class honours.

Career

He turned down an offer to study for a doctorate and instead worked as an assistant lecturer at the University of Glasgow.

In 1951 he joined the pharmaceutical company Glaxo Laboratories, moving to Smith Kline and French in 1953. In 1961 he became director of research at Allen and Hanburys, a subsidiary of Glaxo, and served as Glaxo's research and development director from 1978 until his official retirement in 1987. Jack was known for heading a group which developed salbutamol, ranitidine, beclometasone, salmeterol, fluticasone propionate, ondansetron and sumatriptan.

Honours

Jack was knighted for services to the pharmaceutical industry in 1993.

In 1987, he was awarded an Honorary Degree (Doctor of Science) by the University of Bath.

References

David Jack (scientist) Wikipedia